Guest Editorial Cataract: Demands and Fresh Insights  
back to contents
Correspondence:
John M Sparrow
Bristol Eye Hospital
Lower Maudlin Street
Bristol
BS1 2LX

John M Sparrow
D Phil, FRCS, FRCOphth
Consultant Ophthalmologist
Bristol Eye Hospital
Lower Maudlin Street
Bristol
BS1 2LX
 

Cataract: Demands and fresh insights

As the leading global cause of avoidable visual impairment loss of sight from cataract remains a major and unresolved world health problem 1. In this issue of CE Optometry a number of key issues in relation to cataract are discussed. The scale of the problem is vast. Developed nations vary in their ability to cope with the demand for surgical services and developing nations grapple with huge backlogs of cataract blindness. Many individuals in under privileged societies spend the final years of their lives blind for want of a surgical procedure which takes less than half an hour to deliver. Current projections based on expected demographic shifts towards increased longevity suggest that the problem of unmet need for cataract services will steadily increase. By the year 2020, the number of blind people is likely to have increased from the present 50M to 75M, with 35M or 45% of these blind from bilateral unoperated cataract. In addition there are expected to be at least 3 times this number of people with severe visual impairment due to cataract (Johnson, this issue).

There are many challenges in relation to cataract. These vary with time and place, and historical perspectives help to shed light on successes and failures (Munton, this issue). Broadly, the issues fall into two areas: service provision for established disease; and research to aid understanding of the causes of cataract with a view to development of non-surgical interventions and /or risk modification strategies. Defining the size of the surgical problem is a complex task (Minassian & Reidy, this issue). Ideally this should be based on assessments which include a self reported perception of a visual problem, impaired quality of life related to vision, willingness to undergo surgery, impaired visual function, as judged by reduced corrected visual acuity and possibly contrast sensitivity, cataract morphology (Pesudovs & Elliott, this issue), and consideration of ocular and systemic co-morbidity2. Cross sectional prevalence surveys can be used to provide ‘snap-shot’ estimates of current unmet need, although attempts at defining population needs for surgery by means of age structured models of survey data are fraught with inaccuracies. Cohort studies of incident disease through time are costly and difficult to perform, but would provide more secure information upon which to base plans for service delivery. In resource restricted health care environments, overt discussion of rationing would be helpful if based on principles of equity, backed by randomised trials of surgical intervention at various thresholds of pre-operative morbidity. Such decision making algorithms would need to include subgroups with ocular co-morbidity as the prevalence of conditions such as age related maculopathy and glaucoma in cataract populations is high. Over simplification, such as denial of second eye surgery following successful first eye surgery fails to address some of the main issues3 and the current UK policy guidance offered in the ‘Action on Cataract’ statement4 acknowledges the need for routine second eye cataract surgery where clinically indicated. High volume surgery for routine operations is becoming established with many surgeons now performing >8 operations during an operating session. The development of multi-professional integrated care pathways standardise and streamline processes and facilitate audit and quality control at each stage of the care delivery system. Thus, routine pre-operative and post-operative assessments may be performed by non-medically qualified team members such as nurses and optometrists (Green, this issue) with no loss of quality of care. Technological advances have resulted in the widespread uptake of phako-emulsification surgery (Lavin, this issue) and improvements in IOL materials and design offer opportunities for decreasing the rate of posterior capsular opacification and the consequent need for laser capsulotomy (Percival, this issue). In the developing nations the challenges faced are far more extreme, with real issues of long term blindness and high rates of unsuccessful surgery. Barriers to access are both cultural and resource based, and include fear of surgery, low expectations, inability to travel, lack of surgical infrastructure, and a lack of adequate numbers of trained health care providers, including surgeons. Manufacture of cheap but safe IOLs should offer some hope for improved surgery in impoverished societies.

Efforts to identify modifiable causes of cataract have had limited success. Aetiological epidemiology has probed risk factors in many populations and a number of risks have emerged as relevant to cataract development5. Demographic risk factors are dominated by the effect of increased age, with females carrying a slightly higher risk than males. As with many other medical conditions, smoking, excessive intake of alcohol and lower socio-economic status are associated with increased risk. Environmental exposure to UV-B appears to carry a higher risk for cortical cataract, which is also commoner among people of African origin. Cataract is associated with various general health problems, including diabetes, systemic hypertension, and the use of certain drugs, for example steroids. Nutrition has been implicated and anti-oxidant vitamins may be protective. To date no intervention studies have demonstrated a clear benefit from the use of anti-cataract medications, although the temptation to pursue this approach is strong, because an intervention with even a moderate delaying effect on cataract progression could significantly decrease the need for cataract surgery in older populations. Recent results from twin studies indicate that there is a strong genetic component for the development of both nuclear and cortical cataract 6,7. Approaches directed towards risk modification by manipulation of environmental and lifestyle exposures may now need to be modified and possibly restricted to individuals with a family history of cataract. The dream of genetic manipulation of the lens and its environment, if ever realised, remains far in the future.

With many health care systems struggling to provide adequately for the needs of those afflicted by cataract, pragmatism demands that current efforts focus upon issues of surgical provision. Individual patients, will in the future, judge health care provision on the quality of their sight following the onset of cataract. Those who suffer the personal tragedy of severe loss of sight from untreated cataract will continue to bear testament to failure.

 
back to top
 

1. Thylefors B, Negrel A-D, Pararajasegaram R, Dadzie KY. Available data on Blindness. WHO programme for the prevention of blindness. Geneva: World Health Organization; 1995.

2. Frost NA, Hopper CD, Frankel SJ, Peters TJ, Durant JS, Sparrow JM. The population requirement for cataract extraction: a cross sectional study. In Press: Eye.

3. Laidlaw DAH, Harrad RA, Hopper CD, Whitaker A, Donovan JL, Brookes ST, Marsh GW, Peters TJ, Sparrow JM, Frankel SJ. Randomised trial of the effectiveness of second eye cataract surgery. Lancet 1998; 352:925-929.

4. NHS Executive. Action on Cataract, good practice guidance. Department of Health, Feb 2000.

5. West SK, Valmadrid CT. Epidemiology of rsk factors for age related cataract. Surv Ophthalmol 1995; 39,323-334.

6. Hammond CJ, Snieder H, Spector TD, Gilbert CE. Genetic and environmental factors in age-related nuclear cataracts in monozygotic and dizygotic twins. N Engl J Med. 2000;342:1786-1790.

7. Hammond CJ, Duncan DD, Snieder H, de Lange ME, West SK, Spector TD, Gilbert CE. The heritability of age-related cortical cataract: the twin eye study. Invest Ophthalmol Vis Sci. 2001;42:601-605.